Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies
Contenu
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Titre
Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies
Sujet
Description
Nearly 10 months after the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the virus responsible for coronavirus disease 2019 (Covid-19), therapeutic options remain limited.
Date
2020-12-10
Type
Citer ce document
Huang, Edmund, and Stanley C. Jordan. 2020. "Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies." New England Journal of Medicine 383 (24):2387-8.
Accessibilité
Free online on NEJM.
Was this resource helpful?